In agreement with findings from the Ovarian Tumor Tissue Analysis (OTTA) consortium study [22], our cohort demonstrated a high median ER expression rate of 70%, consistent with prior analyses of treatment-naive and relapsed HGSC samples [23]. The gene discussed is ESR1; the disease is ovarian neoplasm.